Literature DB >> 3025825

ACTH-(1-24) and alpha-MSH antagonize feeding behavior stimulated by kappa opiate agonists.

R Poggioli, A V Vergoni, A Bertolini.   

Abstract

ACTH-(1-24) and alpha-MSH, intracerebroventricularly (ICV) injected at the doses of 4 and 10 micrograms/animal, respectively, markedly inhibited spontaneous feeding in adult Sprague-Dawley rats, the effect remaining significant for 6-9 hours. At these same doses, ACTH-(1-24) and alpha-MSH abolished the feeding-stimulatory effect of the kappa opiate receptor agonist pentazocine, intraperitoneally (IP) injected at the dose of 10 mg/kg. The same antagonism was obtained by ICV injection of ACTH-(1-24) into rats IP treated with other kappa opiate agonists, bremazocine and tifluadom, at the doses of 1 and 5 mg/kg, respectively. These data suggest that melanocortin peptides play an inhibitory role in the complex regulation of food intake, and further support and extend the hypothesis of a melanocortin-opioid homeostatic system, its two neuropeptide components usually having opposite, mutually-balancing effects.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025825     DOI: 10.1016/0196-9781(86)90104-x

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  39 in total

Review 1.  Alan [corrected] N. Epstein award: Intracellular signaling and ingestive behaviors.

Authors:  Derek Daniels
Journal:  Physiol Behav       Date:  2010-03-25

2.  A Macrocyclic Agouti-Related Protein/[Nle4,DPhe7]α-Melanocyte Stimulating Hormone Chimeric Scaffold Produces Subnanomolar Melanocortin Receptor Ligands.

Authors:  Mark D Ericson; Katie T Freeman; Sathya M Schnell; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2017-01-17       Impact factor: 7.446

3.  Autoantibodies against alpha -MSH, ACTH, and LHRH in anorexia and bulimia nervosa patients.

Authors:  Sergueï O Fetissov; Jarmila Hallman; Lars Oreland; Britt Af Klinteberg; Eva Grenbäck; Anna-Lena Hulting; Tomas Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-16       Impact factor: 11.205

4.  Anatomical dissociation of melanocortin receptor agonist effects on taste- and gut-sensitive feeding processes.

Authors:  John-Paul Baird; Mariana Palacios; Michael LaRiviere; Lindsay A Grigg; Christopher Lim; Eduardo Matute; Julia Lord
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-07-06       Impact factor: 3.619

Review 5.  Peptides and their potential role in the treatment of diabetes and obesity.

Authors:  Hannah C Greenwood; Stephen R Bloom; Kevin G Murphy
Journal:  Rev Diabet Stud       Date:  2011-11-10

Review 6.  Mitochondrial dynamics in the central regulation of metabolism.

Authors:  Carole M Nasrallah; Tamas L Horvath
Journal:  Nat Rev Endocrinol       Date:  2014-09-09       Impact factor: 43.330

7.  A fragment of the Escherichia coli ClpB heat-shock protein is a micromolar melanocortin 1 receptor agonist.

Authors:  Mark D Ericson; Sathya M Schnell; Katie T Freeman; Carrie Haskell-Luevano
Journal:  Bioorg Med Chem Lett       Date:  2015-09-21       Impact factor: 2.823

8.  Comparative Intracerebroventricular and Intrathecal Administration of a Nanomolar Macrocyclic Melanocortin Receptor Agonist MDE6-5-2c (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro]) Decreases Food Intake in Mice.

Authors:  Danielle N Adank; Mary M Lunzer; Mark D Ericson; Zoe M Koeperich; Stacey L Wilber; Katlyn A Fleming; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2020-09-10       Impact factor: 4.418

9.  Mechanisms by which the orexigen NPY regulates anorexigenic α-MSH and TRH.

Authors:  Nicole E Cyr; Anika M Toorie; Jennifer S Steger; Matthew M Sochat; Samantha Hyner; Mario Perello; Ronald Stuart; Eduardo A Nillni
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-01-15       Impact factor: 4.310

10.  Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balance.

Authors:  N M Semjonous; K L Smith; J R C Parkinson; D J L Gunner; Y-L Liu; K G Murphy; M A Ghatei; S R Bloom; C J Small
Journal:  Int J Obes (Lond)       Date:  2009-06-02       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.